Main Article Content
Background: Rheumatoid arthritis (RA) is a chronic systemic disease, characterized by autoimmunity. One of the most specific and important diagnostic and prognostic markers of RA are antibodies, Anti Cyclic Citrullinated Protein Antibodies (ACPA).
Objective: The purpose of this study was to investigate the association between ACPA (Anti-CCP) levels and radiological damage.
Methods: An observational Cross-sectional study included 54 patients fulfilling the ACR-EULAR 2010 criteria for RA, with minimum disease duration of 1 year. Radiographs were scored using a modified Sharp score (Van der Heijde modification of Sharp's score 1989). ACPA levels were determined using immunofluorescence assay.
Results: ACPA levels were strongly associated with radiographic severity and there was a significant relationship between ACPA levels and total Sharp score (p=0.0001).
Conclusion: This study concluded that ACPA is an independent severity factor for RA, and our data supports the association between ACPA and radiographic severity.
Weisman M. Definition and Classification. Rheumatoid Arthritis. New York: Oxford University Press. 2011;5-10.
Živkovi N, Stankovi A, Krsti I, Kosti T, Ili N. Influence of joint damage on functional capacities in patients suffering from rheumatoid arthritis. Acta Med Media. 2009;48(2):18-21.
Heidari B. Rheumatoid Arthritis: Early diagnosis and treatment outcomes. Caspian journal of internal medicine. 2011;2(1):161.
Weisman M. Laboratory and Imaging Assessments. Rheumatoid Arthritis. New York: Oxford University Press. 2011;55-60
Song YW, Kang EH. Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. QJM: An International Journal of Medicine. 2010;103(3):139-46.
Rocha SD, Baldo DC, Andrade LE. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Advances in Rheumatology. 2019;59.
Peterfy CG, Wu C, Lu Y, Genovese M. Comparison of the Genant-modified Sharp and van der Heijde-modified Sharp scoring methods for radiographic assessment in rheumatoid arthritis. International Journal of Clinical Rheumatology. 2011;6(1):15.
Shankar S, Grover R, Handa R. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis. Indian Journal of Medical Research. 2006;124(6):689-96.
Andrade F, Darrah E, Rosen A. Autoantibodies in Rheumatoid Arthritis. In: Gary S. Firestein, Sherine E. Gabriel, Iain B. McInnes, James R. O’Dell. (eds) Kelley and firestein’s textbook of rheumatology, tenth edition. Philadelphia: Elsevier. 2017;831-845.
Vossenaar ER, van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clinical and Applied Immunology Reviews. 2004;4(4):239-62.
Bahadur M, Singh P, Satyawali V, Joshi A. Role of DMARD Naïve Period in the Development of Severe Rheumatoid Arthritis. Indian Journal of Orthopaedics. 2020;1-5.
Jilani AA, Mackworth-Young CG. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis. International journal of rheumatology; 2015.
Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. Journal of the Association of Physicians. 2007;100(4): 193-201.